613 related articles for article (PubMed ID: 25445341)
21. Ultra-efficient PrP(Sc) amplification highlights potentialities and pitfalls of PMCA technology.
Cosseddu GM; Nonno R; Vaccari G; Bucalossi C; Fernandez-Borges N; Di Bari MA; Castilla J; Agrimi U
PLoS Pathog; 2011 Nov; 7(11):e1002370. PubMed ID: 22114554
[TBL] [Abstract][Full Text] [Related]
22. Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies.
Candelise N; Schmitz M; Da Silva Correia SM; Arora AS; Villar-Piqué A; Zafar S; Llorens F; Cramm M; Zerr I
Expert Rev Mol Diagn; 2017 Oct; 17(10):897-904. PubMed ID: 28817974
[TBL] [Abstract][Full Text] [Related]
23. Cyclic amplification of protein misfolding: application to prion-related disorders and beyond.
Soto C; Saborio GP; Anderes L
Trends Neurosci; 2002 Aug; 25(8):390-4. PubMed ID: 12127750
[TBL] [Abstract][Full Text] [Related]
24. Synthetic Prion Selection and Adaptation.
Bistaffa E; Moda F; Virgilio T; Campagnani I; De Luca CMG; Rossi M; Salzano G; Giaccone G; Tagliavini F; Legname G
Mol Neurobiol; 2019 Apr; 56(4):2978-2989. PubMed ID: 30074230
[TBL] [Abstract][Full Text] [Related]
25. Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins.
Eraña H; Venegas V; Moreno J; Castilla J
Biochem Biophys Res Commun; 2017 Feb; 483(4):1125-1136. PubMed ID: 27590581
[TBL] [Abstract][Full Text] [Related]
26. Kinetics of Abnormal Prion Protein in Blood of Transgenic Mice Experimentally Infected by Multiple Routes with the Agent of Variant Creutzfeldt-Jakob Disease.
Yakovleva O; Pilant T; Asher DM; Gregori L
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515154
[TBL] [Abstract][Full Text] [Related]
27. Species-barrier phenomenon in prion transmissibility from a viewpoint of protein science.
Hagiwara K; Hara H; Hanada K
J Biochem; 2013 Feb; 153(2):139-45. PubMed ID: 23284000
[TBL] [Abstract][Full Text] [Related]
28. In vitro prion protein conversion suggests risk of bighorn sheep (Ovis canadensis) to transmissible spongiform encephalopathies.
Morawski AR; Carlson CM; Chang H; Johnson CJ
BMC Vet Res; 2013 Aug; 9():157. PubMed ID: 23938169
[TBL] [Abstract][Full Text] [Related]
29. Molecular dynamics studies on the NMR and X-ray structures of rabbit prion proteins.
Zhang J; Zhang Y
J Theor Biol; 2014 Feb; 342():70-82. PubMed ID: 24184221
[TBL] [Abstract][Full Text] [Related]
30. Towards further reduction and replacement of animal bioassays in prion research by cell and protein misfolding cyclic amplification assays.
Boerner S; Wagenführ K; Daus ML; Thomzig A; Beekes M
Lab Anim; 2013 Apr; 47(2):106-15. PubMed ID: 23479773
[TBL] [Abstract][Full Text] [Related]
31. Protein misfolding cyclic amplification of prions.
Saunders SE; Bartz JC; Shikiya RA
J Vis Exp; 2012 Nov; (69):. PubMed ID: 23168797
[TBL] [Abstract][Full Text] [Related]
32. In Vitro Conversion Assays Diagnostic for Neurodegenerative Proteinopathies.
Singh S; DeMarco ML
J Appl Lab Med; 2020 Jan; 5(1):142-157. PubMed ID: 31811072
[TBL] [Abstract][Full Text] [Related]
33. Preparation of lyophilized recombinant prion protein for TSE diagnosis by RT-QuIC.
Hwang S; Tatum T; Lebepe-Mazur S; Nicholson EM
BMC Res Notes; 2018 Dec; 11(1):895. PubMed ID: 30547851
[TBL] [Abstract][Full Text] [Related]
34. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
[TBL] [Abstract][Full Text] [Related]
35. Reconstructing prions: fibril assembly from simple yeast to complex mammals.
Sigurdson C; Polymenidou M; Aguzzi A
Neurodegener Dis; 2005; 2(1):1-5. PubMed ID: 16908997
[TBL] [Abstract][Full Text] [Related]
36. Infectious prions and proteinopathies.
Barron RM
Prion; 2017 Jan; 11(1):40-47. PubMed ID: 28281925
[TBL] [Abstract][Full Text] [Related]
37. Prion protein interconversions.
Caughey B
Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):197-200; discussion 200-2. PubMed ID: 11260800
[TBL] [Abstract][Full Text] [Related]
38. Prion diseases: a riddle wrapped in a mystery inside an enigma.
Liberski PP
Folia Neuropathol; 2008; 46(2):93-116. PubMed ID: 18587704
[TBL] [Abstract][Full Text] [Related]
39. The Prion Concept and Synthetic Prions.
Legname G; Moda F
Prog Mol Biol Transl Sci; 2017; 150():147-156. PubMed ID: 28838659
[TBL] [Abstract][Full Text] [Related]
40. Cofactors influence the biological properties of infectious recombinant prions.
Fernández-Borges N; Di Bari MA; Eraña H; Sánchez-Martín M; Pirisinu L; Parra B; Elezgarai SR; Vanni I; López-Moreno R; Vaccari G; Venegas V; Charco JM; Gil D; Harrathi C; D'Agostino C; Agrimi U; Mayoral T; Requena JR; Nonno R; Castilla J
Acta Neuropathol; 2018 Feb; 135(2):179-199. PubMed ID: 29094186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
